Medicare Enrolled
Dr. Dwayne Griffin, D.O.
Pulmonary Disease · Petoskey, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Griffin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Griffin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Griffin
Dr. Dwayne Griffin is a pulmonary disease specialist in Petoskey, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Griffin performed 5,976 Medicare services across 4,877 unique beneficiaries.
Between the years covered by Open Payments, Dr. Griffin received a total of $17,463 from 57 pharmaceutical and/or device companies across 894 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Griffin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in MI
$17,463 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,976
Medicare services
Top 2% in MI for pulmonary disease
4,877
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~315 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,086 | $85 | $165 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,003 | $126 | $223 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
380 | $9 | $26 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
380 | $6 | $20 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
326 | $18 | $78 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
304 | $7 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
267 | $107 | $254 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
242 | $14 | $22 |
| New patient office visit, complex (60-74 min) | 233 | $152 | $318 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
223 | $61 | $112 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
213 | $82 | $125 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
71 | $107 | $381 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
47 | $10 | $100 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
35 | $87 | $356 |
| Ultrasound scan of chest An imaging test that uses sound waves to create pictures of the structures inside the chest. |
34 | $42 | $191 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
28 | $87 | $330 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
28 | $25 | $44 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
25 | $12 | $38 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
23 | $236 | $676 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $65 | $166 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
11 | $11 | $324 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,463
Total received (2018-2024)
Avg $2,495/year across 7 years
Top 6% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
894
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,375 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$88 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,952
2023
$3,932
2022
$3,080
2021
$2,554
2020
$1,430
2019
$1,440
2018
$1,075
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,009
GlaxoSmithKline, LLC.
$521
Inspire Medical Systems, Inc.
$353
GENZYME CORPORATION
$288
Regeneron Healthcare Solutions, Inc.
$250
Amgen Inc.
$217
JAZZ PHARMACEUTICALS INC.
$191
Axsome Therapeutics, Inc.
$184
Grifols USA, LLC
$158
Mylan Specialty L.P.
$148
Resmed Corp
$118
Boehringer Ingelheim Pharmaceuticals, Inc.
$113
HARMONY BIOSCIENCES LLC
$88
Actelion Pharmaceuticals US, Inc.
$81
Insmed, Inc.
$46
INOGEN, INC.
$32
United Therapeutics Corporation
$24
Bayer Healthcare Pharmaceuticals Inc.
$20
Genentech USA, Inc.
$20
PFIZER INC.
$19
Pulmonx Corporation
$19
Avadel CNS Pharmaceuticals, LLC
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
ZOLL Respicardia, Inc.
$14
Breas Medical, Inc.
$13
Top 3 companies account for 47.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,187
GlaxoSmithKline, LLC.
$2,323
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,733
GENZYME CORPORATION
$1,044
Regeneron Healthcare Solutions, Inc.
$843
Grifols USA, LLC
$749
Mylan Specialty L.P.
$564
JAZZ PHARMACEUTICALS INC.
$559
Harmony Biosciences LLC
$464
Inspire Medical Systems, Inc.
$454
Amgen Inc.
$449
Resmed Corp
$341
Actelion Pharmaceuticals US, Inc.
$340
Jazz Pharmaceuticals Inc.
$262
Axsome Therapeutics, Inc.
$254
HARMONY BIOSCIENCES LLC
$219
Sunovion Pharmaceuticals Inc.
$191
Insmed, Inc.
$184
Penumbra, Inc.
$175
Pulmonx Corporation
$142
Merck Sharp & Dohme LLC
$138
Electromed, Inc.
$133
Philips Electronics North America Corporation
$120
Merck Sharp & Dohme Corporation
$115
Mallinckrodt LLC
$115
Mallinckrodt Hospital Products Inc.
$112
Takeda Pharmaceuticals U.S.A., Inc.
$104
Inari Medical, Inc.
$88
Eisai Inc.
$88
Teva Pharmaceuticals USA, Inc.
$86
E.R. Squibb & Sons, L.L.C.
$79
Genentech USA, Inc.
$73
Advanced Respiratory, Inc
$61
Alexion Pharmaceuticals, Inc.
$56
United Therapeutics Corporation
$52
ABBVIE INC.
$50
Circassia Pharmaceuticals Inc
$39
PFIZER INC.
$37
Bayer HealthCare Pharmaceuticals Inc.
$37
Shire North American Group Inc
$35
Gilead Sciences, Inc.
$34
INOGEN, INC.
$32
Mallinckrodt Enterprises LLC
$31
Janssen Pharmaceuticals, Inc
$31
Vapotherm Inc
$30
Allergan Inc.
$26
IDORSIA PHARMACEUTICALS US INC
$23
Baxter Healthcare
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Novo Nordisk Inc
$17
Novartis Pharmaceuticals Corporation
$16
Boston Scientific Corporation
$15
Avadel CNS Pharmaceuticals, LLC
$14
ADMA BioManufacturing LLC
$14
ZOLL Respicardia, Inc.
$14
Breas Medical, Inc.
$13
La Jolla Pharmaceutical Company
$13
Top 3 companies account for 47.2% of all-time payments
Associated products mentioned in payments ›
(2547) Sleep Other · (8275) DreamStation Cpap Auto · (8874) inCourage · ACTHAR · AIRCURVE · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirCurve · AirDuo Digihaler · AirSense · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · CHARTIS CATHETER · CINQAIR · CUTAQUIG · DIFICID · DUPIXENT · Dayvigo · DreamWisp · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · GAMMAGARD · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · INVOKANA · Indigo System · KEYTRUDA · Kerendia · LATUDA · LOKELMA · LONHALA MAGNAIR · LUMRYZ · NUCALA · OFEV · OPDIVO · OPSUMIT · PREVNAR 20 · Perforomist · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · Rybelsus · S · SHINGRIX · SMARTVEST · SOLIRIS · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TRINTELLIX · TUDORZA PRESSAIR · TYVASO · The MetaNeb System · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON · Ultomiris · Utibron · VAPOTHERM · VRAYLAR · Veklury · Vivo 45 LS · WAKIX · Wakix · WaveWriter Alpha Prime 16 · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZERBAXA · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for pulmonary disease in MI.
Geographic Context
Pulmonary diseases within 10 mi
5
Per 100K population
14.6
County median income
$73,724
Nearest hospital
MCLAREN NORTHERN MICHIGAN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Griffin is a clinical cardiology specialist, with above-average Medicare volume (top 2% in MI), with low-engagement industry engagement in the top 6% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Griffin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Griffin performed 2,086 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Griffin receive payments from pharmaceutical companies?
Yes. Dr. Griffin received a total of $17,463 from 57 companies across 894 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Griffin's costs compare to other pulmonary diseases in Petoskey?
Dr. Griffin's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Griffin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Petoskey
Browse pulmonary diseases in Petoskey ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in MI
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in MI
Which MI pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology